Eurobio Scientific Société anonyme (EPA:ALERS)
France · Delayed Price · Currency is EUR 20.00
-0.40 (-1.96%)
Aug 21, 2026, 5:13 PM CET
EPA:ALERS Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 200 | 245 | 254 | 168 | 221 | 292 | |
Market Cap Growth | -20.77% | -3.33% | 50.69% | -23.80% | -24.43% | 52.26% |
Enterprise Value | 196 | 235 | 260 | 204 | 134 | 236 |
Last Close Price | 19.90 | 24.35 | 25.25 | 16.46 | 20.36 | 26.92 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 42.34 | 50.39 | 63.43 | 34.81 | 8.86 | 4.83 |
Forward PE | 17.61 | 25.50 | 25.38 | 17.33 | 10.63 | 7.73 |
PS Ratio | 1.19 | 1.45 | 1.64 | 1.29 | 1.44 | 1.58 |
PB Ratio | 1.09 | 1.33 | 1.42 | 0.96 | 1.28 | 1.82 |
P/TBV Ratio | 3.34 | 4.08 | 4.38 | 3.06 | 4.00 | 2.08 |
P/FCF Ratio | 31.89 | 39.02 | 18.86 | 7.41 | 5.49 | 4.56 |
P/OCF Ratio | 10.63 | 13.01 | 15.18 | 6.29 | 5.13 | 4.43 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.16 | 1.39 | 1.69 | 1.56 | 0.88 | 1.28 |
EV/EBITDA Ratio | 8.72 | 10.48 | 9.51 | 8.76 | 3.31 | 3.03 |
EV/EBIT Ratio | 18.22 | 21.88 | 19.53 | 20.12 | 4.35 | 3.37 |
EV/FCF Ratio | 31.15 | 37.41 | 19.37 | 8.98 | 3.33 | 3.69 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.09 | 0.09 | 0.06 | 0.57 | 0.66 | 0.10 |
Debt / EBITDA Ratio | 0.71 | 0.71 | 0.36 | 4.32 | 2.81 | 0.20 |
Debt / FCF Ratio | 2.55 | 2.55 | 0.73 | 4.43 | 2.82 | 0.25 |
Net Debt / Equity Ratio | -0.02 | -0.02 | -0.07 | 0.07 | 0.16 | -0.54 |
Net Debt / EBITDA Ratio | -0.21 | -0.21 | -0.48 | 0.50 | 0.68 | -1.11 |
Net Debt / FCF Ratio | -0.74 | -0.74 | -0.99 | 0.51 | 0.69 | -1.35 |
Asset Turnover | 0.66 | 0.66 | 0.54 | 0.40 | 0.57 | 0.97 |
Inventory Turnover | 3.30 | 3.30 | 3.43 | 3.40 | 4.30 | 5.88 |
Quick Ratio | 1.65 | 1.65 | 1.76 | 2.26 | 2.18 | 4.28 |
Current Ratio | 2.64 | 2.64 | 2.67 | 2.72 | 2.59 | 4.81 |
Return on Equity (ROE) | 2.68% | 2.68% | 2.26% | 2.78% | 14.94% | 45.06% |
Return on Assets (ROA) | 2.61% | 2.61% | 2.91% | 1.96% | 7.14% | 22.93% |
Return on Invested Capital (ROIC) | 3.74% | 3.88% | 4.81% | 3.63% | 18.87% | 81.45% |
Return on Capital Employed (ROCE) | 4.80% | 4.80% | 6.00% | 3.80% | 11.30% | 40.40% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 2.43% | 1.98% | 1.58% | 2.87% | 11.29% | 20.71% |
FCF Yield | 3.14% | 2.56% | 5.30% | 13.50% | 18.22% | 21.92% |
Buyback Yield / Dilution | - | - | 8.63% | 1.40% | -4.59% | 3.35% |